Viewing Study NCT04121403


Ignite Creation Date: 2025-12-24 @ 7:48 PM
Ignite Modification Date: 2025-12-30 @ 2:45 AM
Study NCT ID: NCT04121403
Status: COMPLETED
Last Update Posted: 2024-12-16
First Post: 2019-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
Sponsor: Oslo University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module